Stocks · Health care · Surgical & Medical Instruments & Apparatus

SkinHealth Systems Inc.

SKIN Clue Score43
United States Fiscal year ends December CIK 0001818093
$0.55 -3.32% Close, 9 Oct 2026
Price $0.55 −97.74% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 24 Nov 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue166.6Operating income13.5Net income−1.6EPS, diluted−0.05Fiscal year 2020Revenue119.1 −28.5%Operating income−17.2Net income−29.2EPS, diluted−0.85Fiscal year 2021Revenue260.1 +118.4%Operating income−39.9Net income−378.8EPS, diluted−3.71Fiscal year 2022Revenue365.9 +40.7%Operating income−25.8Net income44.2EPS, diluted−0.23Fiscal year 2023Revenue398.0 +8.8%Operating income−130.9Net income−100.1 −326.4%EPS, diluted−0.76Fiscal year 2024Revenue334.3 −16.0%Operating income−67.8Net income−29.1EPS, diluted−0.36Fiscal year 2025Revenue300.8 −10.0%Operating income−20.8Net income−9.5EPS, diluted−0.16
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 166.6 119.1 260.1 365.9 398.0 334.3 300.8
Growth −28.5% +118.4% +40.7% +8.8% −16.0% −10.0%
Operating income 13.5 −17.2 −39.9 −25.8 −130.9 −67.8 −20.8
Net income −1.6 −29.2 −378.8 44.2 −100.1 −29.1 −9.5
Growth −326.4%
EPS, diluted −0.05 −0.85 −3.71 −0.23 −0.76 −0.36 −0.16

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin63.9%Operating margin8.1%Net margin−1.0%Free cash flow margin−4.2%Fiscal year 2020Gross margin56.4%Operating margin−14.4%Net margin−24.5%Free cash flow margin−13.4%Fiscal year 2021Gross margin68.6%Operating margin−15.4%Net margin−145.6%Free cash flow margin−15.2%Fiscal year 2022Gross margin68.0%Operating margin−7.1%Net margin12.1%Free cash flow margin−32.1%Fiscal year 2023Gross margin39.0%Operating margin−32.9%Net margin−25.2%Free cash flow margin4.5%Fiscal year 2024Gross margin54.5%Operating margin−20.3%Net margin−8.7%Free cash flow margin4.6%Fiscal year 2025Gross margin65.3%Operating margin−6.9%Net margin−3.2%Free cash flow margin12.4%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 63.9% 56.4% 68.6% 68.0% 39.0% 54.5% 65.3%
Operating margin 8.1% −14.4% −15.4% −7.1% −32.9% −20.3% −6.9%
Net margin −1.0% −24.5% −145.6% 12.1% −25.2% −8.7% −3.2%
Free cash flow margin −4.2% −13.4% −15.2% −32.1% 4.5% 4.6% 12.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow1.7Capital expenditure−8.8Free cash flow−7.0Buybacks0.0Fiscal year 2020Operating cash flow−12.4Capital expenditure−3.5Free cash flow−15.9Buybacks−0.2Fiscal year 2021Operating cash flow−28.4Capital expenditure−11.2Free cash flow−39.6Buybacks0.0Fiscal year 2022Operating cash flow−106.6Capital expenditure−10.8Free cash flow−117.4Buybacks−160.0Fiscal year 2023Operating cash flow21.8Capital expenditure−3.8Free cash flow17.9Buybacks−30.2Fiscal year 2024Operating cash flow16.1Capital expenditure−0.8Free cash flow15.4 −14.2%Buybacks0.0Fiscal year 2025Operating cash flow37.5Capital expenditure−0.3Free cash flow37.2 +141.8%Buybacks0.0
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 1.7 −12.4 −28.4 −106.6 21.8 16.1 37.5
Capital expenditure −8.8 −3.5 −11.2 −10.8 −3.8 −0.8 −0.3
Free cash flow −7.0 −15.9 −39.6 −117.4 17.9 15.4 37.2
Growth −14.2% +141.8%
Buybacks 0.0 −0.2 0.0 −160.0 −30.2 0.0 0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash7.3Shareholders’ equity−1.2Fiscal year 2020Cash9.5Shareholders’ equity−30.6Fiscal year 2021Cash901.9Shareholders’ equity298.0Fiscal year 2022Cash568.2Shareholders’ equity167.1Fiscal year 2023Cash523.0Shareholders’ equity59.4Fiscal year 2024Cash370.1Total debt552.2Net cash (debt)−182.1Shareholders’ equity51.8Debt to equity10.66Fiscal year 2025Cash232.7Shareholders’ equity61.1
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 7.3 9.5 901.9 568.2 523.0 370.1 232.7
Total debt n/a n/a n/a n/a n/a 552.2 n/a
Net cash (debt) n/a n/a n/a n/a n/a −182.1 n/a
Shareholders’ equity −1.2 −30.6 298.0 167.1 59.4 51.8 61.1
Debt to equity n/a n/a n/a n/a n/a 10.66 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
1.7 −12.4 −28.4 −106.6 21.8 16.1 37.5
Growth −819.7% −25.8% +132.3%
Investment
−8.8 −3.5 −11.2 −10.8 −3.8 −0.8 −0.3
calc −7.0 −15.9 −39.6 −117.4 17.9 15.4 37.2
Growth −14.2% +141.8%
calc −0.22 −0.46 −0.39 −0.79 0.14 0.11 0.27
−12.5 −3.8 −37.7 −18.9 −31.5 −6.8 −5.2
Financing
14.6 18.3 959.0 −205.2 −37.4 −158.3 −174.9
0.0 −0.2 0.0 −160.0 −30.2 0.0 0.0

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.